{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:27:03Z","timestamp":1792596423620,"version":"4.5.0"},"reference-count":63,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"AMR-One Health Consortium Major Innovation Fund Program"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2021,12,22]]},"abstract":"<jats:p>\n            This work describes the epidemiology of invasive infections caused by the bacterium group B\n            <jats:named-content content-type=\"genus-species\">Streptococcus<\/jats:named-content>\n            (GBS) in Alberta, Canada. We show that rates of invasive GBS disease have increased from 2014 to 2020 for both adult disease and late-onset disease in neonates, whereas the rate of early onset disease in neonates has decreased. We also show that the rate of resistance to erythromycin (an antibiotic used to treat GBS) has also increased in this time.\n          <\/jats:p>","DOI":"10.1128\/spectrum.01283-21","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T20:23:54Z","timestamp":1636662234000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["Epidemiological Characterization of Group B Streptococcus Infections in Alberta, Canada: An Update from 2014 to 2020"],"prefix":"10.1128","volume":"9","author":[{"given":"Angela","family":"Ma","sequence":"first","affiliation":[{"name":"Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0775-5062","authenticated-orcid":true,"given":"L. Alexa","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Corsiatto","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Hurteau","sequence":"additional","affiliation":[{"name":"Alberta Precision Laboratories\u2014Provincial Laboratory for Public Health, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5276-2416","authenticated-orcid":true,"given":"Gregory J.","family":"Tyrrell","sequence":"additional","affiliation":[{"name":"Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada"},{"name":"Alberta Precision Laboratories\u2014Provincial Laboratory for Public Health, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00437"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-09843-2_35"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0007-2018"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.01.009"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.1.83-89.2004"},{"issue":"10","key":"e_1_3_2_7_2","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease\u2014revised guidelines from CDC, 2010","volume":"59","author":"Verani JR","year":"2010","unstructured":"Verani JR, McGee L, Schrag SJ. 2010. Prevention of perinatal group B streptococcal disease\u2014revised guidelines from CDC, 2010. MMWR Recomm Rep 59(RR-10):1\u201336.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2009.02.011"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020205"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(97)00587-5"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix655"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.03.024"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(73)80524-4"},{"key":"e_1_3_2_14_2","first-page":"1205","article-title":"Early-onset and late-onset neonatal group B streptococcal disease\u2013United States, 1996\u20132004","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","unstructured":"Centers for Disease Control and Prevention. 2005. Early-onset and late-onset neonatal group B streptococcal disease\u2013United States, 1996\u20132004. MMWR Morb Mortal Wkly Rep 54:1205\u20131208.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306243282503"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/599369"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.3105"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4046703"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02417-12"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.11599\/germs.2015.1080"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2004.04266.x"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2014.10.007"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03554-13"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/315699"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix656"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00355-16"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2016.09.042"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0849-5831(16)31386-6"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2005.07.003"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1155\/2002\/352613"},{"key":"e_1_3_2_31_2","first-page":"479","article-title":"Physicians\u2019 prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions","volume":"164","author":"Davies HD","year":"2001","unstructured":"Davies HD, Adair CE, Schuchat A, Low DE, Sauve RS, McGeer A. 2001. Physicians\u2019 prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions. CMAJ 164:479\u2013485.","journal-title":"CMAJ"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2511.181647"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-1881"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098778"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.4826"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.04.020"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-018-1192-x"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.11.008"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2019.07.001"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-03864-1"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00049-18"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix658"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2005.46.4.480"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa151"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-011-1298-7"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125985"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01128-15"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01615-16"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2014.140759"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.67"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis605"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.11.3205-3208.2001"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1368942"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00264"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-03992-8"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.08.023"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.02.021"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S203454"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.142.1.165"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.57.4.571"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2009.11.010"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00300-17"},{"key":"e_1_3_2_63_2","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2020","unstructured":"Clinical and Laboratory Standards Institute. 2020. Performance standards for antimicrobial susceptibility testing, 30th ed. CLSI M100. CLSI, Wayne, PA.","edition":"30"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9019-8_23"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/Spectrum.01283-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/Spectrum.01283-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T08:44:50Z","timestamp":1646729090000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/Spectrum.01283-21"}},"subtitle":[],"editor":[{"given":"Jennifer Dien","family":"Bard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,22]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12,22]]}},"alternative-id":["10.1128\/Spectrum.01283-21"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.01283-21","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,22]]},"assertion":[{"value":"2021-08-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01283-21"}}